Breaking the Barriers: Improving Access to Biologic Therapies in IBD

Viewing Options


Topic Information

Target Audience

This webcast will target members of the health care team who navigate the prior authorization process and provide practical tools and strategies to minimize access barriers to biologic therapies in IBD.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the clinical rationale for biologic therapies in IBD and their potential for improving patient outcomes.

Communicate effectively with payers regarding PA requirements for biologic therapies in IBD.

Incorporate practical tools to reduce the prior authorization burden and facilitate timely approval of biologics in IBD.

Release Date: 08/02/2018
Expiration Date: 08/02/2019   
*This program has expired. CME credit is no longer available.

Accreditation Statement

ANCC Accreditation

Annenberg Center for Health Sciences is accredited as a provider of continuing
nursing education by the American Nurses Credentialing Center's Commission on

A maximum of 0.5 contact hours may be earned for successful completion of this activity.

AANP Accreditation

Annenberg Center for Health Sciences at Eisenhower is accredited by the
American Association of Nurse Practitioners as an approved provider of nurse
practitioner continuing education. Provider number: 040207.

This program is accredited for 0.5 contact hours. Program ID #5611.

AAPA Accreditation

This activity has been reviewed by the AAPA Review Panel and is compliant with
AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits.
Approval is valid for one year from 08/02/2018. PAs should only claim
credit commensurate with the extent of their participation.

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., all other staff at the Annenberg Center for Health Sciences at Eisenhower and GI Health Foundation have no relationships to disclose.

Faculty Disclosures:

Sharon Dudley-Brown
Consultant: AbbVie

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Provided by:

Accredited by

© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.